ABC101-1, a novel microtubule inhibitor antibody-drug conjugate targeting HER2, has potent anti-tumor activity in a breast cancer model

被引：0
|
作者：
Kim, Seo Woo
Yu, Hana
Lee, Geon Ho
Lim, Tae Gyu
Jeong, Minji
Hwang, Hyeonjoo
Moon, Jee Eun
Lee, Yong Beom
Jin, Sung-Ha
Jeong, Jin Hyun
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 03期
关键词：
D O I：
10.1158/1538-7445.ADVBC23-B030
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B030
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A novel topoisomerase I inhibitor antibody-drug conjugate targeting CEACAM5 has potent anti-tumor activity in colorectal cancer models
    Baudat, Yves
    Neff-LaFord, Haley
    Nicolazzi, Celine
    Meyer, Dave
    Sigurjonsson, Johann Petur
    Lyski, Ryan
    Fantin, Valeria
    Brun, Marie-Priscille
    Chiron, Marielle
    Decary, Stephanie
    CANCER RESEARCH, 2023, 83 (07)
  • [2] DB-1310, a HER3-targeting antibody-drug conjugate, has synergistic anti-tumor activity with trastuzumab in HER2- and HER3-expressing breast cancer
    Xi Li
    Liwen Liang
    Zhongyuan Zhu
    Haiqing Hua
    Yang Qiu
    Cancer Biology & Medicine, 2025, 22 (03) : 231 - 236
  • [3] DB-1310, a HER3-targeting antibody-drug conjugate, has synergistic anti-tumor activity with trastuzumab in HER2and HER3-expressing breast cancer
    Li, Xi
    Liang, Liwen
    Zhu, Zhongyuan
    Hua, Haiqing
    Qiu, Yang
    CANCER BIOLOGY & MEDICINE, 2025,
  • [4] A novel dual drug antibody-drug conjugate targeting hTrop2 has synergetic anti-tumor activity by enhancing systemic immunity
    Zhu, Jie
    Zhao, Xiaobei
    Luo, Zhenwu
    Li, Eileen
    Xu, Hong
    Wu, Cindy
    Chen, Gang
    Nie, Lei
    Wang, Haibin
    CANCER IMMUNOLOGY RESEARCH, 2025, 13 (02)
  • [5] Tumor targeting of a STING agonist with an antibody-drug conjugate elicits potent anti-tumor immune responses
    Cetinbas, Naniye Malli
    Catcott, Kalli
    Avocetien, Kenneth
    Bentley, Keith
    Carter, Tyler
    Chin, Chen-Ni
    Clardy, Susan
    Eitas, Timothy
    Jones, Brian
    Kelleher, Eoin
    Mosher, Rebecca
    Nazzaro, Mark
    Nehilla, Barrett
    Protopopova, Marina
    Shaw, Pamela
    Slocum, Kelly
    Qin, LiuLiang
    Thomas, Josh
    Yang, Liping
    Toader, Dorin
    Damelin, Marc
    Duvall, Jeremy
    Bukhalid, Raghida
    Lowinger, Timothy
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [6] Potent anti-tumor activity of T-DM1 antibody-drug conjugate in combination with chemotherapeutic agents in breast tumor cells
    Parsons, K.
    Fields, C.
    Gunter, B.
    Phillips, G.
    Tibbitts, J.
    EJC SUPPLEMENTS, 2010, 8 (07): : 35 - 35
  • [7] A novel bispecific antibody drug conjugate targeting HER2 and HER3 with potent therapeutic efficacy against breast cancer
    Zong, Hui-fang
    Li, Xi
    Han, Lei
    Wang, Lei
    Liu, Jun-jun
    Yue, Ya-li
    Chen, Jie
    Ke, Yong
    Jiang, Hua
    Xie, Yue-qing
    Zhang, Bao-hong
    Zhu, Jian-wei
    ACTA PHARMACOLOGICA SINICA, 2024, 45 (08) : 1727 - 1739
  • [8] Novel PIKK inhibitor antibody-drug conjugates: Synthesis and anti-tumor activity
    Zhou, Dahui
    Casavant, Jeffrey
    Graziani, Edmund, I
    He, Haiyin
    Janso, Jeffrey
    Loganzo, Frank
    Musto, Sylvia
    Tumey, Nathan
    O'Donnell, Christopher J.
    Dushin, Russell
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (07) : 943 - 947
  • [9] A novel bispecific antibody-drug conjugate targeting HER2 and Trop-2 displays potent antitumor activity in a variety of tumor models with promising preclinical characteristics
    Zhong, Haihong
    Xiong, Yan
    Huang, Han
    Pan, Yuming
    Wang, Na
    Sun, Bin
    Liu, Shen
    Yuan, Wei
    Liu, Dingguo
    Fang, Jan
    Bao, Haifeng
    CANCER RESEARCH, 2024, 84 (06)
  • [10] A novel antibody-drug conjugate, HcHAb18-DM1, has potent anti-tumor activity against human non-small cell lung cancer
    Huhe, Muren
    Lou, Jiaxin
    Zhu, Yumeng
    Zhao, Yu
    Shi, Ying
    Wang, Bo
    Sun, Xiuxuan
    Zhang, Xiaoqin
    Zhang, Yang
    Chen, Zhi-Nan
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 513 (04) : 1083 - 1091
12345